Combination low-intensity chemotherapy plus inotuzumab ozogamicin, blinatumomab and rituximab for pediatric patients with relapsed/refractory B-cell acute lymphoblastic leukemia.
Haematologica
; 2024 May 23.
Article
in En
| MEDLINE
| ID: mdl-38779719
ABSTRACT
Not available.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Haematologica
Year:
2024
Document type:
Article